Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats
Khalid A El-Saiy, Rabab H. Sayed, Ayman E. El-Sahar, et al.
Chemico-Biological Interactions (2022) Vol. 354, pp. 109841-109841
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Exploring the Role of Ubiquitin–Proteasome System in Parkinson's Disease
Tapan Behl, Sachin Kumar, Ziyad M. Althafar, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4257-4273
Closed Access | Times Cited: 39
Microtubule acetylation dyshomeostasis in Parkinson’s disease
Padmashri Naren, Khan Sabiya Samim, Kamatham Pushpa Tryphena, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 29
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Poojitha Pinjala, Kamatham Pushpa Tryphena, Renuka Prasad, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 25
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats
Heba A. Farid, Rabab H. Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 2, pp. 1421-1437
Open Access | Times Cited: 23
Role of histone deacetylases and their inhibitors in neurological diseases
Liying Zhang, Sen-Yu Zhang, Ri Wen, et al.
Pharmacological Research (2024), pp. 107410-107410
Open Access | Times Cited: 12
New insight into interference-free and highly sensitive dopamine electroanalysis
A.G. Kamaha Tchekep, V. Suryanarayanan, Deepak K. Pattanayak
Analytica Chimica Acta (2024) Vol. 1291, pp. 342234-342234
Closed Access | Times Cited: 8
Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
Brain Research (2023) Vol. 1815, pp. 148462-148462
Closed Access | Times Cited: 18
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Yan Li, Zhicheng Gu, Shuxian Lin, et al.
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 672-672
Open Access | Times Cited: 22
Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway
Eman S. Zaki, Rabab H. Sayed, Muhammed A. Saad, et al.
Life Sciences (2023) Vol. 327, pp. 121806-121806
Closed Access | Times Cited: 13
An Overview of Epigenetic Changes in the Parkinson’s Disease Brain
Anthony Klokkaris, Anna Migdalska‐Richards
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6168-6168
Open Access | Times Cited: 4
Repurposing ezetimibe as a neuroprotective agent in a rotenone-induced Parkinson’s disease model in rats: Role of AMPK/SIRT-1/PGC-1α signaling and autophagy
Wessam H. Elesawy, Ayman E. El-Sahar, Rabab H. Sayed, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112640-112640
Closed Access | Times Cited: 4
Epigenetic mechanisms of rapid-acting antidepressants
Antonio Inserra, Antonella Campanale, Tamim Rezai, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Current genetic data on depression and anxiety in Parkinson's disease patients
Kallirhoe Kalinderi, Vasileios Papaliagkas, Liana Fidani
Parkinsonism & Related Disorders (2023) Vol. 118, pp. 105922-105922
Closed Access | Times Cited: 9
Association between Parkinson’s Disease and Cancer: New Findings and Possible Mediators
Andrei Surguchov, Alexei Surguchev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3899-3899
Open Access | Times Cited: 2
Curcumin prevents neurodegeneration by blocking HDAC6–NLRP3 pathway-dependent neuroinflammation in Parkinson’s disease
Ziwei Cai, Congmin Liang, Kai-Lun Huang, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113928-113928
Closed Access | Times Cited: 2
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
Efthalia Angelopoulou, Anastasia Bougea, Yam Nath Paudel, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1138-1138
Open Access | Times Cited: 6
Synucleinopathies: Intrinsic and Extrinsic Factors
Alma Karen Lomeli-Lepe, José Luis Castañeda‐Cabral, Silvia Josefina López‐Pérez
Cell Biochemistry and Biophysics (2023) Vol. 81, Iss. 3, pp. 427-442
Closed Access | Times Cited: 6
Exercise-Boosted Mitochondrial Remodeling in Parkinson’s Disease
Juan Carlos Magaña, Cláudia M. Deus, Maria Giné‐Garriga, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3228-3228
Open Access | Times Cited: 10
Radix Actinidiae chinensis induces the autophagy and apoptosis in renal cell carcinoma cells
Biao Liu, Yuanliang Yan, Liang Zhang
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1
Ubiquitin Proteasome System and Microtubules Are Master Regulators of Central and Peripheral Nervous System Axon Degeneration
Daniele Cartelli, Guido Cavaletti, Giuseppe Lauria, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1358-1358
Open Access | Times Cited: 7
Histone Deacetylases as Epigenetic Targets for Treating Parkinson’s Disease
Yan Li, Zhicheng Gu, Shu-xian Lin, et al.
(2022)
Open Access | Times Cited: 7
Autophagy and Its Association with Genetic Mutations in Parkinson Disease
Nour S. Erekat
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 5
Venlafaxine, an anti-depressant drug, induces apoptosis in MV3 human melanoma cells through JNK1/2-Nur77 signaling pathway
Ting Niu, Zhiying Wei, Jiao Fu, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 2
Abolished clustering of MeCP2T158M can be partially reverted with small molecules
Rodrigo Lata, Liesbeth Steegmans, Ranie Kellens, et al.
Translational Medicine Communications (2024) Vol. 9, Iss. 1
Open Access
The degradation of α--synuclein is limited by dynein to drive the AALP pathway through HDAC6 upon paraquat exposure
Qi Ai, Kaidong Wang, Yujing Li, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 283, pp. 116841-116841
Closed Access
Page 1 - Next Page

Scroll to top